# ImmuCell Corporation (ICCC) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $2M |
| 2024 | -$2M |
| 2023 | -$6M |
| 2022 | -$2M |
| 2021 | $257,385 |
| 2020 | -$1M |
| 2019 | -$953,908 |
| 2018 | -$1M |
| 2017 | -$242,845 |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $2M |
| 2025-09-30 | $20,075 |
| 2025-06-30 | $569,562 |
| 2025-03-31 | $1M |
| 2024-09-30 | -$574,894 |
| 2024-06-30 | -$1M |
| 2024-03-31 | -$300,052 |
| 2023-09-30 | -$1M |
| 2023-06-30 | -$1M |
| 2023-03-31 | -$2M |
| 2022-09-30 | -$616,790 |
| 2022-06-30 | -$619,007 |
| 2022-03-31 | $570,609 |
| 2021-09-30 | $271,090 |
| 2021-06-30 | $215,508 |
| 2021-03-31 | -$374,625 |
| 2020-09-30 | -$251,598 |
| 2020-06-30 | -$691,269 |
| 2020-03-31 | $196,877 |
| 2019-09-30 | -$429,816 |
| 2019-06-30 | -$546,932 |
| 2019-03-31 | $265,304 |
| 2018-09-30 | -$149,140 |
| 2018-06-30 | -$193,409 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ICCC/operating-income)